Brown Brothers Harriman & Co’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $573K | Sell |
2,047
-105
| -5% | -$27.6K | ﹤0.01% | 668 |
|
|
2026
Q1 | $574K | Buy |
2,152
+1,228
| +133% | +$333K | ﹤0.01% | 553 |
|
|
2025
Q4 | $232K | Buy |
924
+17
| +2% | +$4.51K | ﹤0.01% | 720 |
|
|
2025
Q3 | $260K | Buy |
907
+78
| +9% | +$20.9K | ﹤0.01% | 626 |
|
|
2025
Q2 | $218K | Buy |
829
+180
| +28% | +$43.8K | ﹤0.01% | 613 |
|
|
2025
Q1 | $151K | Sell |
649
-4
| -0.6% | -$971 | ﹤0.01% | 619 |
|
|
2024
Q4 | $150K | Buy |
653
+207
| +46% | +$47.5K | ﹤0.01% | 635 |
|
|
2024
Q3 | $99.7K | Buy |
446
+3
| +0.7% | +$659 | ﹤0.01% | 691 |
|
|
2024
Q2 | $90.2K | Sell |
443
-30
| -6% | -$6.1K | ﹤0.01% | 676 |
|
|
2024
Q1 | $103K | Hold |
473
| – | – | ﹤0.01% | 638 |
|
|
2023
Q4 | $108K | Sell |
473
-33
| -7% | -$6.93K | ﹤0.01% | 605 |
|
|
2023
Q3 | $102K | Sell |
506
-348
| -41% | -$73.4K | ﹤0.01% | 595 |
|
|
2023
Q2 | $177K | Hold |
854
| – | – | ﹤0.01% | 498 |
|
|
2023
Q1 | $168K | Buy |
854
+15
| +2% | +$3.09K | ﹤0.01% | 518 |
|
|
2022
Q4 | $170K | Hold |
839
| – | – | ﹤0.01% | 501 |
|
|
2022
Q3 | $148K | Buy |
839
+276
| +49% | +$56.5K | ﹤0.01% | 523 |
|
|
2022
Q2 | $113K | Sell |
563
-1,061
| -65% | -$226K | ﹤0.01% | 561 |
|
|
2022
Q1 | $368K | Buy |
1,624
+1,089
| +204% | +$256K | ﹤0.01% | 390 |
|
|
2021
Q4 | $145 | Buy |
535
+1
| +0.2% | +$248 | ﹤0.01% | 534 |
|
|
2021
Q3 | $129 | Sell |
534
-374
| -41% | -$94.3K | ﹤0.01% | 523 |
|
|
2021
Q2 | $215 | Buy |
908
+362
| +66% | +$82.5K | ﹤0.01% | 424 |
|
|
2021
Q1 | $120 | Sell |
546
-492
| -47% | -$98.7K | ﹤0.01% | 493 |
|
|
2020
Q4 | $182K | Buy |
1,038
+498
| +92% | +$86K | ﹤0.01% | 456 |
|
|
2020
Q3 | $87K | Sell |
540
-19
| -3% | -$3.01K | ﹤0.01% | 511 |
|
|
2020
Q2 | $80K | Sell |
559
-831
| -60% | -$115K | ﹤0.01% | 518 |
|
|
2020
Q1 | $151K | Sell |
1,390
-2,060
| -60% | -$297K | ﹤0.01% | 390 |
|
|
2019
Q4 | $501K | Sell |
3,450
-150
| -4% | -$21.7K | ﹤0.01% | 312 |
|
|
2019
Q3 | $520K | Buy |
3,600
+3,278
| +1,018% | +$478K | ﹤0.01% | 286 |
|
|
2019
Q2 | $48K | Buy |
322
+3
| +0.9% | +$419 | ﹤0.01% | 594 |
|
|
2019
Q1 | $42K | Sell |
319
-845
| -73% | -$104K | ﹤0.01% | 611 |
|
|
2018
Q4 | $126K | Hold |
1,164
| – | – | ﹤0.01% | 408 |
|
|
2018
Q3 | $174K | Buy |
1,164
+1,012
| +666% | +$154K | ﹤0.01% | 382 |
|
|
2018
Q2 | $24K | Buy |
152
+150
| +7,500% | +$22.6K | ﹤0.01% | 571 |
|
|
2018
Q1 | $0 | Sell |
2
-118
| -98% | -$17.3K | ﹤0.01% | 985 |
|
|
2017
Q4 | $16K | Buy |
+120
| New | +$15.9K | ﹤0.01% | 681 |
|
Other funds holding LH
Brown Brothers Harriman & Co's LH Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its Labcorp (LH) stake by 4.9% in Q2 2026, selling an estimated $27.6K and leaving 2,047 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #668.
Brown Brothers Harriman & Co first reported a position in LH in Q4 2017 and has held it in 35 quarters since. The position peaked at $574K in Q1 2026. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Brown Brothers Harriman & Co held 2,047 shares of Labcorp worth $573K as of Q2 2026.
- Brown Brothers Harriman & Co sold 105 Labcorp shares in Q2 2026, an estimated $27.6K.
- Labcorp made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #668 holding.
- Brown Brothers Harriman & Co first reported a position in Labcorp in Q4 2017 and has held it in 35 quarters since.
- Brown Brothers Harriman & Co's Labcorp position peaked at $574K in Q1 2026.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.